SKI Market

Indian Indices

Nifty

25,597.65 -165.70
(-0.64%)

Sensex

83,459.15 -519.34
( -0.62%)

Bank Nifty

57,827.05 -274.40
( -0.47%)

Nifty IT

35,274.55 -378.50
( -1.06%)

Global Indices

Nasdaq

47,102.64 -255.05
(-0.54%)

Dow Jones

6,792.56 -80.41
(-1.17%)

Hang Seng

50,042.66 -1,454.54
(-2.82%)

Nikkei 225

9,700.69 -0.68
(-0.01%)

Forex

USD-INR

88.75 0.20
(0.23%)

EUR-INR

102.26 0.13
(0.13%)

GBP-INR

116.57 0.18
(0.16%)

JPY-INR

0.58 0.00
(0.17%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Neuland Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

524558

INE794A01010

1182.3025819

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

NEULANDLAB

173.16

22589.01

EPS(TTM)

Face Value()

Div & Yield %

101.68

0.07

Back

Mercury Laboratories standalone net profit rises 185.29% in the June 2025 quarter

Aug 13,2025

Net profit of Mercury Laboratories rose 185.29% to Rs 0.97 crore in the quarter ended June 2025 as against Rs 0.34 crore during the previous quarter ended June 2024. Sales rose 8.75% to Rs 18.14 crore in the quarter ended June 2025 as against Rs 16.68 crore during the previous quarter ended June 2024.

Particulars	Quarter Ended
	Jun. 2025	Jun. 2024	% Var.
Sales	18.14	16.68	9
OPM %	13.01	9.65	-
PBDT	2.39	1.62	48
PBT	1.55	0.92	68
NP	0.97	0.34	185

25,597.65 -165.70 (-0.64%)

83,459.15 -519.34 ( -0.62%)

57,827.05 -274.40 ( -0.47%)

35,274.55 -378.50 ( -1.06%)

47,102.64 -255.05 (-0.54%)

6,792.56 -80.41 (-1.17%)

50,042.66 -1,454.54 (-2.82%)

9,700.69 -0.68 (-0.01%)

88.75 0.20 (0.23%)

102.26 0.13 (0.13%)

116.57 0.18 (0.16%)

0.58 0.00 (0.17%)